Триметоприм

Quick links

Choose a section

Quick links to important sections

Advertisements

Триметоприм

Advertisements
Advertisements

Overview of Триметоприм

Quick Facts: Trimethoprim

Property Description
Active ingredient Trimethoprim (TMP)
Form Tablet, Oral Solution, Injectable
Pharmacological Class Antibacterial agent, Dihydrofolate reductase inhibitor
Common Use Management of bacterial infections
Origin Synthetic compound

What Type of Medicine is Trimethoprim (Триметоприм)?

Триметоприм (Trimethoprim) is a synthetic antibacterial agent primarily categorized as a dihydrofolate reductase inhibitor belonging to the diaminopyrimidine chemical class. It is recognized on the WHO Essential Medicines List due to its efficacy and public health relevance. The use of Trimethoprim is for controlling the spread of infections caused by susceptible pathogens, such as those commonly implicated in certain uncomplicated urinary tract issues. Its general therapeutic purpose is to control the presence of bacterial pathogens by intervening directly in essential microbial life processes.


Composition, Forms, and Action Overview

The active substance, Trimethoprim (C14H18N4O3), is available for use as a single agent in forms such as tablets for oral administration and sterile injectable formulations for intravenous delivery. Trimethoprim functions as an antifolate agent, meaning it interferes with the bacteria's ability to create folate (a B vitamin compound). By selectively inhibiting a key bacterial enzyme, the medicine prevents the microbes from synthesizing the necessary building blocks for their DNA and protein. This action effectively stops bacteria from growing and multiplying, thereby managing the infection.


Single Agent vs. Fixed-Dose Combination (Co-trimoxazole)

Trimethoprim can be prescribed alone as a stand-alone monotherapy drug, particularly when the avoidance of sulfa drugs is necessary due to patient sensitivity. However, it is also frequently formulated as a fixed-dose combination product with the antibiotic Sulfamethoxazole, known internationally as Co-trimoxazole. The combination is considered a distinct strategy because the two agents work synergistically, attacking the bacterial folate production pathway at two separate, sequential steps, resulting in a more effective combined antimicrobial action.

Advertisements

What side effects are possible with Триметоприм?

Possible Side Effects and Safety Information

Trimethoprim is generally well-tolerated, but like all medications, it can cause side effects. Most common reactions are typically mild and often involve the gastrointestinal system or skin.


Common Side Effects

  • Gastrointestinal: Nausea, vomiting, diarrhea, stomach cramps.
  • Skin: Rash (including mild, itchy rash), and pruritus (itching).
  • Other: Headache, inflammation of the tongue (glossitis).

Serious Side Effects

While rare, certain serious side effects require immediate medical attention. Contact your healthcare provider right away if you experience:

  • Severe Allergic Reaction: Signs of anaphylaxis, such as hives, swelling of the face, lips, tongue, or throat, or difficulty breathing.
  • Severe Skin Reactions: Any blistering, peeling, or widespread rash, which can be signs of life-threatening conditions like Stevens-Johnson syndrome or Toxic Epidermal Necrolysis.
  • Blood Disorders: Signs of blood count abnormalities (e.g., thrombocytopenia, leukopenia) which may present as unusual bleeding or bruising, persistent sore throat, fever, or paleness.
  • Clostridioides difficile (C. diff)-Associated Diarrhea: Severe, watery, or bloody diarrhea that occurs during or even months after treatment.
  • Hyperkalemia: High potassium levels, which can cause muscle weakness, irregular heartbeat, or chest pain.

Important Safety Information and Precautions

  • Drug Interactions: Trimethoprim can interact with several medications, including warfarin (increasing bleeding risk), certain diuretics (increasing the risk of low platelet count), and methotrexate (increasing toxicity). Always inform your doctor and pharmacist of all drugs and supplements you are taking.
  • Folate Deficiency: Trimethoprim can interfere with folic acid metabolism. It is contraindicated in patients with a history of megaloblastic anemia due to folate deficiency.
  • Photosensitivity: This medication can make your skin more sensitive to sunlight. It is recommended to limit sun exposure, wear protective clothing, and use sunscreen while taking trimethoprim.
  • Pre-existing Conditions: Use with caution in patients with kidney or liver disease or a known folate deficiency, as dose adjustments or close monitoring may be necessary.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

The official overdose profile for Trimethoprim distinguishes between two main types of exposure: acute (single, large dose) and chronic (large doses taken over prolonged periods). Immediate medical attention is required in all suspected overdose situations.

Overdose Manifestations (as documented) Severe Outcomes & Required Monitoring
Acute: Vomiting, confusion, loss of consciousness, fever, and jaundice (yellowing of the skin/eyes). Chronic: Interference with the hematopoietic system, leading to serious blood disorders such as megaloblastic anemia.
Chronic: Signs of serious blood disorders, including fever, sore throat, pallor, or purpura. Risk of significant hyperkalemia (high blood potassium) is noted, requiring serum electrolyte monitoring.

In cases of life-threatening symptoms such as collapse, a seizure, or trouble breathing, emergency services (911) must be called immediately. For all other suspected overdoses, immediately contact a poison control center or seek emergency medical attention as directed by government guidance. Treatment is primarily symptomatic and supportive. For chronic overdose effects, regulatory information confirms the specific use of Leucovorin (folinic acid) to counteract the documented hematologic toxicity.

Advertisements

Therapeutic Uses of Триметоприм

What Триметоприм Treats: Main Uses and Benefits

The therapeutic application of Trimethoprim is focused on managing specific bacterial infections, generally offering both treatment for acute episodes and supportive prevention. The primary use is to treat and prevent urinary tract infections (UTIs), such as cystitis. The medication is commonly used across conditions presenting with acute episodes and is applied across domains where additional symptomatic support is needed.

Management of Acute Bacterial Urinary Discomfort

Trimethoprim is commonly used in conditions presenting with acute, uncomplicated infections of the lower urinary tract, a clinical situation often characterized by symptoms related to physical discomfort, such as painful, burning urination (dysuria) and urinary frequency. The therapeutic benefit is applied in addressing the infection that causes these symptoms, which may help to ease the discomfort and assist with maintaining functional stability during these disruptive episodes.

“This medication is considered relevant in contexts involving heightened systemic burden due to susceptible bacterial infections.”

Supportive Management for Recurrent Infections

Beyond treating an active flare-up, this medication is applied in regimens that may be part of symptomatic management to help reduce the likelihood of recurrence of specific bacterial issues in patients prone to repeated urinary tract infections. This continuous supportive strategy contributes to easing the overall symptom load and supports the patient during difficult episodes by easing distress. The medication is also considered relevant in contexts involving heightened systemic burden due to susceptible bacterial infections, such as those causing severe diarrhea or particular types of pneumonia (PJP) in susceptible individuals, particularly when used in fixed combination.

Quick Fact: Relief for Acute Discomfort
Primary Indication Focus Uncomplicated bacterial urinary tract infections (UTIs).
Symptom Domain Addressed Painful urination and frequent urge (dysuria).
Supportive Benefit Assists with maintaining functional stability during symptomatic periods.
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Trimethoprim

Official regulatory documents define specific population groups who are eligible or prohibited from using Trimethoprim.

Contraindicated Populations (Must Not Use)

Trimethoprim is contraindicated for patients with a known hypersensitivity to the drug, documented megaloblastic anemia due to folate deficiency, or a history of drug-induced immune thrombocytopenia. Use is also prohibited in infants less than 2 months of age and in patients with severe hepatic damage or severe renal insufficiency where monitoring is not possible.


Age and Condition-Based Restrictions

Population Group Regulatory Status Restriction Details
Infants (< 2 months) Contraindicated Prohibited due to safety concerns.
Children (< 12 years) Use Not Established Efficacy for uncomplicated urinary tract infections (UTIs) is not established with the single-agent tablet.
Renal Impairment Restricted/Not Recommended Requires dosage reduction for Creatinine Clearance (CrCl) 15 to 30 mL/min; not recommended if CrCl is lower.
Pregnancy/Lactation Conditional Use Classified as Pregnancy Category C; use during pregnancy only if potential benefit justifies the risk to the fetus. Caution is advised during lactation.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Trimethoprim can affect and be affected by other medications through its mechanisms of action, primarily related to drug metabolism enzymes and transporter systems.

Interacting Product Category Potential Effect of the Interaction
Potassium-Elevating Agents (e.g., ACE Inhibitors, ARBs, potassium supplements) Increased risk of hyperkalemia (high potassium levels). Trimethoprim can reduce potassium elimination from the kidney.
Anticoagulants (Oral) (e.g., Warfarin) Increased risk of bleeding due to a potential enhancement of the anticoagulant effect.
Certain Diabetes Medications (e.g., Repaglinide, Sulfonylureas) Increased risk of hypoglycemia (low blood sugar), as Trimethoprim may inhibit the metabolism of these drugs (via CYP2C8 inhibition).
Antiarrhythmics (e.g., Dofetilide) Combination is generally not recommended as Trimethoprim may increase the concentration of the antiarrhythmic agent, increasing the risk of serious side effects.
Antifolate Agents (e.g., Methotrexate) Increased risk of hematologic toxicity (e.g., bone marrow suppression, megaloblastic anemia) due to the additive antifolate effect of both drugs.
Phenytoin Increased concentration and half-life of Phenytoin, potentially leading to signs of toxicity.

Close monitoring of blood counts and serum potassium levels is essential, particularly in elderly patients, those with existing renal impairment, or when using high doses or prolonged treatment courses.

Advertisements

Mechanism of Action

Selective Inhibition of Bacterial DHFR Enzyme

This mechanism acts as a highly specific competitive inhibitor of the enzyme dihydrofolate reductase (DHFR) within bacterial cells. By occupying the active site of the bacterial enzyme, Trimethoprim prevents the conversion of dihydrofolate (DHF) to tetrahydrofolate (THF), initiating a functional disruption in microbial metabolism. The resulting physiological effect is the targeted anti-proliferative action on susceptible pathogens.


Disruption of Microbial DNA Precursor Biosynthesis

The block on THF synthesis depletes the bacterial cell's supply of essential cofactors needed to create purine and pyrimidine bases (thymidine). This action directly halts the biosynthesis of the nucleic acid precursors required for DNA replication and protein synthesis. This molecular cascade leads to the bacteriostatic effect, where the growth and division of the bacterial population are arrested.


Synergistic Double Blockade in Combination Products

When Trimethoprim is used in combination with Sulfamethoxazole, the mechanism is amplified through a sequential double blockade of the folate pathway (an upstream and a downstream step are inhibited). This mutual potentiation results in a more pronounced physiological consequence: the effect shifts from primarily bacteriostatic (growth inhibiting) to bactericidal (killing) for many susceptible organisms, due to the complete and overwhelming shutdown of the pathway.

Advertisements

Dosage and Administration Information

How to Use Trimethoprim (Триметоприм)

The usage of Trimethoprim follows instructions defining the administration route, dosage, and duration. The medication is primarily available for Oral administration in various tablet strengths, including 100 mg and 200 mg monotherapy forms, or in a fixed-dose combination with sulfamethoxazole (Co-trimoxazole), such as the 160 mg TMP / 800 mg SMX Double Strength tablet. An Intravenous (IV) Infusion is reserved for situations where oral administration is not possible or for treating severe systemic infections.

Dosing and Frequency Principles

Standard adult monotherapy for acute, uncomplicated issues involves taking 100 mg every 12 hours or 200 mg once daily. For high-dose requirements, such as treating Pneumocystis pneumonia (PJP) with the combination product, the total daily amount is calculated based on body weight and divided into doses taken two to four times daily.

Administration Requirements and Duration

The oral dose may be taken with or without food, and it is generally recommended to take it with a full glass of water while maintaining adequate fluid intake. The IV solution must be diluted prior to use and administered as a slow infusion over 60 to 90 minutes, with intramuscular injection explicitly restricted. Treatment duration varies significantly, ranging from a short-term 3-day course for specific acute infections to a prolonged 14 to 21-day course for severe conditions.

Special Population Rules

Dosage requires specific adjustments for patients with diminished renal function. Guidelines specify a 50% dose reduction for adults whose creatinine clearance is between 15 and 30 mL/min. For pediatric patients under 12, dosing for the combination product is calculated based on body weight.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Триметоприм


Evidence for Use in Acute Uncomplicated Urinary Tract Infections

The research record exploring conditions associated with acute, uncomplicated infections of the lower urinary tract relies mainly on Randomized Controlled Trials (RCTs). These studies evaluated Trimethoprim across different course lengths and monitored endpoints such as bacteriological cure rate (potential elimination of the pathogen) and clinical cure rate (measured changes in acute symptoms). Findings describe patterns of short-term bacteriological clearance, but the data show variability across studies. Data show patterns related to how bacterial resistance has developed, which is cited as a factor in the variability of measured outcomes. Comparative evidence that fully contrasts Trimethoprim with other standard antibiotic treatments remains limited.


Evidence for Use in Preventing Recurrent Infections (Prophylaxis)

Trimethoprim was evaluated in research exploring its long-term use in individuals prone to repeated urinary tract infections. This prophylaxis has been the subject of RCTs and systematic reviews that tracked the frequency of symptomatic UTI recurrence over defined periods. Studies monitored the emergence of antibiotic resistance in the observed populations. The evidence for long-term prophylaxis is noted in scientific reviews to be classified as moderate because sample sizes were modest in some studies, and certainty remains low for outcomes after the preventative regimen is finished.


Long-Term Study Design and Follow-up

Research exploring acute episodes features follow-up durations limited to a few weeks post-therapy. In contrast, studies for the preventative regimen monitored outcomes over defined intervals, with typical follow-up durations of up to 12 months or more. However, data for assessing the durability of any observed effect after the medication is stopped are still emerging.


Evidence in Special Study Populations

Studies have been conducted to evaluate Trimethoprim's use in children and older adults, examining outcomes linked to inflammatory or systemic imbalance. However, research in these groups is often more limited than in the general adult population. For instance, data for certain groups, such as frail older adults in residential care or older men with recurrent issues, remain insufficient.


What Is Still Uncertain About the Research Record

The research highlights key areas of uncertainty, including the impact of bacterial resistance. Research describes that long-term continuous use was associated with an increase in resistance, and the clinical significance of this finding is not fully established. Furthermore, there is limited information regarding the optimal duration for a preventative regimen, and comparative evidence is lacking against other standard antibiotic treatments in current clinical practice.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Триметоприм (FAQ)

Q: How quickly does Trimethoprim start working?

Studies commonly report the initial clearance of bacteria within the first few days of starting treatment. However, the timeframe for a patient to notice changes in their symptoms can vary depending on the individual and the specific infection being managed.

Q: How is Trimethoprim different from Biseptol?

Триметоприм is available as a single, active drug ingredient. Бисептол, on the other hand, is a common brand name for a combination product called Ко-тримоксазол. This combination contains both Триметоприм and a separate antibacterial substance known as сульфаметоксазол.

Q: Why is Trimethoprim prescribed for urinary tract infections (UTIs)?

According to regulatory documents, Триметоприм's therapeutic indication is the management of infections caused by susceptible organisms. This commonly includes infections that occur in the lower urinary tract.

Q: Is it safe to take Trimethoprim during pregnancy?

Official regulatory documents classify Триметоприм under Pregnancy Category C. This classification is used when animal studies have suggested a risk, but sufficient human studies are lacking. Use during pregnancy is therefore only considered if the potential benefit is judged to outweigh the potential risk to the developing fetus.

Q: How does Trimethoprim affect birth control pills?

Official regulatory information regarding drug interactions does not currently list hormonal contraceptives as an agent with a known, significant interaction with Триметоприм alone. Patients concerned about specific methods or dosage forms should consult the prescribing information for their birth control product.

Q: Is it true that Trimethoprim can cause folic acid deficiency?

The drug functions through an antifolate action, meaning it interferes with the way bacteria use folic acid. Official safety information highlights that the medicine is contraindicated (must not be used) in patients with documented megaloblastic anemia due to a folate deficiency.

Q: Should sun exposure be avoided while taking Trimethoprim?

Regulatory safety information describes that Триметоприм can cause photosensitivity. This means the skin may become more sensitive to sun exposure, which is an important fact to be aware of during treatment.

Q: Why is Trimethoprim considered an 'outdated' drug by some people?

Research summaries indicate that studies have noted patterns related to the development of bacterial resistance to Триметоприм over time. This development of resistance can be a factor contributing to the variability of measured outcomes in different populations.

Q: Can Trimethoprim cause dizziness?

Official product documents list central nervous system effects as possible adverse reactions. Dizziness is described as a possible, though typically uncommon, event associated with the use of this medication.

Q: Can Trimethoprim cause sleep problems?

Official adverse reaction reports include disturbances of the nervous system, such as insomnia (difficulty sleeping). These types of events are generally infrequent, according to official information.

Q: Should Trimethoprim be taken longer than seems necessary?

The duration of treatment is defined in the product's prescribing information to help ensure the therapeutic effect is reached, independent of early changes in symptoms.

Q: What should be done if a dose is missed?

Official patient information generally describes that if a dose is missed, it may be taken as soon as it is remembered. However, if the time for the next scheduled dose is near, the official guidance often suggests the regular schedule be continued, bypassing the missed dose.

Q: What happens if a double dose is taken?

Official safety information concerning overdosage states that taking an acute excess dose may cause temporary side effects such as nausea, vomiting, dizziness, or headache. Chronic overdose, however, is associated with a specific risk of bone marrow suppression.

Q: Does Trimethoprim affect driving ability?

Official product information notes that, since adverse reactions like dizziness or headache may occur, safety information suggests caution may be required for activities requiring focused attention, such as driving or operating machinery.

Q: Why is Trimethoprim sometimes prescribed in combination with other drugs?

Prescribing information notes that Триметоприм may be used in combination with another drug to achieve a synergistic effect, where the two drugs work together to enhance the antimicrobial action. This strategy is also used in regimens intended to treat co-existing infections.

Q: In what cases is Trimethoprim not effective?

The medication is only indicated for the management of infections caused by susceptible strains of microorganisms. This means that Триметоприм is not effective against pathogens that are resistant to its mechanism of action, nor is it effective against viral infections.

Q: Does Trimethoprim help against the common cold or a virus?

Триметоприм is classified specifically as an antibacterial agent that targets bacterial life processes. Official documents state that it is not indicated for the management of viral infections, such as the common cold or flu.

Q: What types of bacteria are sensitive to Trimethoprim?

Official product labels list specific bacterial species and strains that have demonstrated sensitivity to the action of Триметоприм in laboratory settings. This list helps define the range of infections that the drug is indicated to treat.

Q: Can Trimethoprim be used for prevention?

The regulatory indication for Триметоприм includes its use for the management of infections. Furthermore, in some specified patient populations, it may be indicated for the prevention of certain recurring infections, as noted in the product information.

Q: Does Trimethoprim affect blood sugar levels?

The product information notes a potential for increased risk of low blood sugar, known as hypoglycemia, when Триметоприм is administered alongside certain diabetes medications. This effect is thought to occur due to the drug inhibiting the metabolism of the diabetes medicine.

Advertisements

How should Триметоприм be stored and disposed of?

How to Store and Dispose of Trimethoprim

Proper storage and disposal are essential to maintain the quality and safety of Trimethoprim (and its combination products).

Storage Requirements

Store this medication at controlled room temperature, typically between 68 F and 77 F (20 C and 25 C). The medicine must be kept away from excess heat and moisture; therefore, it should not be stored in a bathroom. Keep the medication in its original container, tightly closed, and protect certain forms, such as the oral suspension, from light. It is vital to keep Trimethoprim and all medicines out of the sight and reach of children (e.g., in a locked cabinet or up and away).

Disposal Instructions

Do not use the medicine after the expiration date. Dispose of all unused or expired Trimethoprim safely. The preferred method is using a drug take-back program or authorized collector location. If a take-back option is unavailable, the medicine should be mixed with an undesirable substance (like dirt or coffee grounds) and sealed in a container before discarding it in the household trash, following FDA guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Триметоприм found in:

A-Z Index: